Mechanical heart valves provide much lower mortality than tissue valves in young patients

November 8, 2017- by Steven E. Greer, MD

Off the radar of Wall Street analysts is a new paper in the NEJM that shows mechanical heart valves, both aortic and mitral, impart much lower mortality than tissue valves in the youngest cohort of patients. This paper was not presented at the recent TCT or Euro PCR. Continue reading

Posted in - Medical Devices, - NEJM, Cardiac surgery, Cardiology | Leave a comment

Is President Trump on amphetamines? (Yes, he is)

Update January 16, 2018- by Steven E. Greer, MD

President Trump’s doctor confirms my diagnosis made in the story below, which was that the slurred Continue reading

Posted in - Opinion, - Pharma, - Policy, FDA, Internal Medicine, Neurology, Primary care medicine, Rehab | Leave a comment

Bending the cost curve of cancer care

May 25, 2011- Since the approval of Genentech’s costly Avastin in 2004, prominent oncologists have warned that Continue reading

Posted in - Biotech, - Pharma, CMS, Oncology, VCU | Leave a comment

NBC begins alarming new series to promote the diagnosis of “mental illness” in children

December 11, 2017 Continue reading

Posted in - Opinion, - Pharma, - Policy, CDC, Congress, FDA, Neurology, Neurosurgery, NIH, Pediatrics, Primary care medicine, Psychology Psychiatry, Rehab | Leave a comment

Did Hillary Clinton really faint from “dehydration” or does she have a chronic neurological condition?

September 12, 2016- by Steven E. Greer, MD

Once again, the Hillary Clinton campaign is on defense after another health scare from their Continue reading

Posted in - Policy, Cardiology, Congress, Emergency medicine, Neurology, NYU, Ophthalmology, Primary care medicine, Radiology | Leave a comment

Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer (FLAURA)

November 20, 2017- Interviewed by Steven E. Greer, MD

We interviewed Emory University oncologist Suresh S. Ramalingam, M.D. about his NEJM Continue reading

Posted in - NEJM, Cardiac surgery, Emory, Oncology | Leave a comment

Oh my god, I have a disease!

March 21, 2014- This DTC TV drug ad medicalizing a non-disease really struck us as egregious

Posted in - Pharma, Congress, FDA | Leave a comment

US Senator calls for transparency in medical device pricing

Posted in - Medical Devices, Congress | Leave a comment

HBO’s John Oliver devotes 16-minutes on the Dr. Oz senate hearing

Posted in - Opinion, Cardiac surgery, Congress | Leave a comment

Hormone replacement therapy is safe and effective after all

November 14, 2017- Interviewed by Steven E. Greer, MD

We interviewed JoAnn Manson, MD, DrPH about her JAMA paper that followed the cohorts in Continue reading

Posted in - JAMA, Cardiology, Diabetes and endocrinology, FDA, Geriatrics, Harvard, Obstetrics and Gynecology, Oncology, Orthopedic surgery, Primary care medicine | Leave a comment

Football head injuries down after rules change

NFL-concussionUpdate January 20, 2015- The PBS news show Frontline has been tracking the number Continue reading

Posted in - Opinion, - Policy, Neurosurgery, Primary care medicine, Psychology Psychiatry, Spine surgery, Sports medicine | Leave a comment

Increasing rates of double mastectomies in early stage breast cancer

November 22, 2013- Interviewed by Steven E. Greer, MD

David P. Winchester MD, Medical Director of Cancer Programs for the American College of Surgeons, Continue reading

Posted in - Policy, Oncology, Plastic surgery | Leave a comment

The serious adverse events caused by antipsychotics

February 1, 2014 Continue reading

Posted in - Pharma, FDA | Leave a comment

Steve Bannon and the epidemic of Baby Boomers with mental illness

January 5, 2017- by Steven E. Greer, MD

President Trump made news yesterday by issuing a statement firing back at Steve Bannon for allegations Continue reading

Posted in - Opinion, - Pharma, - Policy, Geriatrics, Neurology, Psychology Psychiatry, Rehab | Leave a comment

CT-scan screening for heart disease fails to show benefit

March 23, 2015- Interviewed by Steven E. Greer, MD

We interviewed the Principal Investigator of the PROMISE trial, Pamela Douglas, MD from Duke. Continue reading

Posted in - NEJM, - Policy, Cardiology, CMS, Duke, Radiology | Leave a comment

What Steve Jobs would have invented if he had lived longer

Steve-JobsUpdate January 29, 2014- Apple posted Q4 earnings so big that they are incomprehensible. Continue reading

Posted in - Medical Devices, - Opinion | Leave a comment

Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis

May 23, 2017- interviewed by Steven E. Greer, MD

We interviewed polumonologist Michael Wechsler, MD about his paper in the NEJM testing mepolizumab Continue reading

Posted in - NEJM, National Jewish Health, Pulmonology, Rheumatology | Leave a comment

The super shady methods of pricing generic drugs in America: case study- Sildenafil

Generic revatioMay 15, 2016- by Steven E. Greer, MD

The last I read, Teva and Mylan were not supposed to launch their approved generic of Viagra (sildenafil) Continue reading

Posted in - Generics, - Opinion, - Pharma, CMS, Congress, FDA | Leave a comment

What 1982’s Blade Runner got right about 2019

September 3, 2017- by Steven E. Greer, MD

I watched again the 1982 classic Blade Runner. Directed by Ridley Scott and starring Harrison Ford, Continue reading

Posted in - Opinion, - Reviews, books, devices, Genetics, Geriatrics, Obstetrics and Gynecology, Oncology, Ophthalmology | Leave a comment

Maybe my brain was spared

July 26, 2017- by Steven E. Greer, MD

Last week, I sat next to an Ohio State University offensive lineman while attending a Roger Waters Continue reading

Posted in - JAMA, - Reviews, books, devices, Neurology, Neurosurgery, Ohio State | Leave a comment